This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Poordad, F. Articles by Landaverde, C. Search for Related Content Social Bookmarking                         What's this?

Review: Rapid virological response to peginterferon alfa and ribavirin treatment of chronic hepatitis C predicts sustained virological response and relapse in genotype 1 patients

Cedars Sinai Medical Center — Medicine, Los Angeles, CA, USA, fred.poordad{at}cshs.org

Carmen Landaverde

UCLA, Medicine, Los Angeles, CA, USA

The treatment of chronic hepatitis C is a rapidly changing arena with new medications, new guidelines, and an evolving understanding of the virus, host factors and natural history. With the explosion of new information, the educational infrastructure to update clinicians has been outpaced; many feel uncertain if the tools they are using to care for patients are meeting the standard of practice. This review focuses on the most common genotype of the hepatitis C virus and the rules of engagement when treating with pegylated interferon and ribavirin. Viral assessment guideposts are evaluated and put into context for a clinical audience. The expected arrival of newer antiviral therapies is still years away, and maximizing the current treatment regimens is of utmost importance to eradicate virus when feasible, while minimizing toxicity.

Key Words: hepatitis C virus • pegylated interferon • ribavirin • positive predictive value • negative predictive value • rapid virologic response • early virologic response • relapse

Therapeutic Advances in Gastroenterology, Vol. 2, No. 2, 91-97 (2009)
DOI: 10.1177/1756283X08101217


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?